Loading candles…
Kopran Ltd. operates in the pharmaceutical industry, manufacturing and supplying pharmaceutical formulations and active pharmaceutical ingredients (APIs) worldwide. The company serves both regulated and non-regulated markets across more than 50 countries. Kopran Ltd. conducts its operations through its formulations segment and its wholly-owned subsidiary, Kopran Research Laboratories Ltd. (KRLL). Its product portfolio includes a diverse therapeutic range focusing on cardiovascular, anti-diabetic, and anti-infective segments. Kopran Ltd. specializes in delivering pharmaceutical products globally, addressing various healthcare needs through its formulations and API verticals.
| To consider and approve the financial results for the period ended March 31, 2025 and dividend |
| 15 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.